Drug General Information |
Drug ID |
D07FCB
|
Former ID |
DNC007498
|
Drug Name |
4-phenyl-1-(1-phenylethyl)piperidin-4-ol
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C19H23NO
|
Canonical SMILES |
CC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O
|
InChI |
1S/C19H23NO/c1-16(17-8-4-2-5-9-17)20-14-12-19(21,13-15-20)18-10-6-3-7-11-18/h2-11,16,21H,12-15H2,1H3
|
InChIKey |
PKTJCXJTMHJHNK-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Mu-type opioid receptor |
Target Info |
Inhibitor |
[1]
|
Nociceptin receptor |
Target Info |
Inhibitor |
[1]
|
Kappa-type opioid receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Neuroactive ligand-receptor interaction
|
Estrogen signaling pathway
|
Morphine addictionhsa04080:Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Opioid prodynorphin pathway
|
Pathway Interaction Database
|
IL4-mediated signaling events
|
Reactome
|
Peptide ligand-binding receptors
|
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
|
G alpha (i) signalling events
|
WikiPathways
|
TCR Signaling Pathway
|
GPCRs, Class A Rhodopsin-like
|
Peptide GPCRs
|
Opioid Signalling
|
GPCR ligand binding
|
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
|
GPCR downstream signaling
|
References |
REF 1 | Bioorg Med Chem Lett. 2007 Jun 1;17(11):3023-7. Epub 2007 Mar 23.Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1. |